Mckesson (MCK) Cash from Financing Activities (2009 - 2026)
Mckesson's (MCK) quarterly Cash from Financing Activities came in at -$2.8 billion in Q1 2026, up 1.23% year-on-year from -$2.8 billion in Q1 2025, and down 39.19% on a QoQ basis from -$2.0 billion in Q4 2025.
Mckesson (MCK) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Cash from Financing Activities data on file, last reported at -$2.8 billion in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 1.23% year-over-year to -$2.8 billion in Q1 2026; TTM through Mar 2026 was -$4.6 billion, a 16.8% decrease from a year earlier, with the FY2026 full-year figure at -$4.6 billion, down 16.8% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$2.8 billion, down from -$2.0 billion in the prior quarter.
- Over the last five years, Cash from Financing Activities for MCK reached as high as $1.3 billion in Q4 2024 and fell as low as -$2.9 billion in Q1 2025.
- Historically, Cash from Financing Activities has averaged -$1.1 billion across 5 years, with a median of -$968.0 million in 2024.
- Across the five-year window, Cash from Financing Activities sank 284.72% in 2022 and jumped 308.68% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at -$1.4 billion in 2022, then surged by 56.35% to -$622.0 million in 2023, then surged by 308.68% to $1.3 billion in 2024, then tumbled by 256.09% to -$2.0 billion in 2025, then sank by 39.19% to -$2.8 billion in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$2.8 billion in Q1 2026, -$2.0 billion in Q4 2025, and -$961.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -2.82 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 3.98 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -483.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 120.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 3.80 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 51.08 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -1.37 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 347,627.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Bn |
| Mar 31, 2026 | -2.82 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Sep 30, 2025 | -961.00 Mn |
| Sep 30, 2025 | -961.00 Mn |
| Jun 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Jun 30, 2024 | -809.00 Mn |
| Jun 30, 2024 | -809.00 Mn |
| Mar 31, 2024 | -968.00 Mn |
| Mar 31, 2024 | -968.00 Mn |
| Dec 31, 2023 | -622.00 Mn |
| Dec 31, 2023 | -622.00 Mn |